Evaluation of the sequence of traditional Chinese medicine based on the practicality of the real world Clinical efficacy of treatment of Rheumatoid Arthritis
Not Applicable
- Conditions
- Rheumatoid Arthritis
- Registration Number
- ITMCTR2100005077
- Lead Sponsor
- ZHEJIANG CHINESE MEDICAL UNIVERSITY
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1. Meet the 2010 ACR/EULAR RA classification standard;
2. 5.1>DAS28>3.2 (at the time of enrollment, the RA patients were in active condition);
3. RA patients with syndrome of spleen deficiency and dampness toxin stasis obstruction;
4. Course of disease <= 24 months;
5. Aged 18 to 65 years;
6. The patient informed and agreed to participate in this study.
Exclusion Criteria
1. Patients with severe organ disease or mental illness;
2. Those who are allergic to the drugs involved in the research protocol or have contraindications to their use.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rheumatoid arthritis disease activity evaluation index DAS28;DAS28 low activity rate;EULAR response standard;DAS28 remission rate;
- Secondary Outcome Measures
Name Time Method Incidence rate;Overall assessment of the patient's own condition PGA;Improvement rate, ACR20/50/70 Improvement rate;Safety index;SDAI remission rate;Quality of life scale SF36;Clinical disease activity index score CDAI;Joint ultrasound score;Health Assessment Questionnaire Disability Index HAQ-DI;Simplified disease activity index score SDAI;TCM syndrome score;Functional Assessment of Treatment of Chronic Diseases-Fatigue FACIT-F;Sharp-van der Heijde score, ?????? Joint ultrasound score;CDAI remission rate;Doctor's overall assessment of the patient's condition MDGA;